Astrazeneca Pharma India Ltd
The Emerging Companies 2026
+ 4 More
+ 4 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
The Emerging Companies
#18(2026)
#18(2026)
Next 500 India
#337(2022)#306(2021)#437(2020)#449(2019)
#337(2022)#306(2021)#437(2020)#449(2019)
Financial Data 2024
Revenue
1,381
(INR Cr)
Net Operating Income
1,296
(INR Cr)
Assets
723
(INR Cr)
Profit
162
(INR Cr)
Net Worth
712
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 1381 28.1% | 1078 33.8% | 806 -2.1% | 823 -6.9% | 884 18.5% | 746 17.6% | 634 17.4% | 540 -4.4% | 565 9.3% | 517 0.0% | 517 27.9% | 404 -26.5% | 550 -10.4% | 614 52.1% | 404 6.5% | 379 - |
| Net Operating Income (INR Cr) | 1296 29.17% | 1003 24.50% | 806 -0.98% | 814 -2.19% | 832 14.21% | 728 27.55% | 571 5.02% | 544 -3.55% | 564 9.02% | 517 9.09% | 474 21.40% | 390 -26.55% | 532 -10.56% | 594 49.81% | 397 12.18% | 354 16.83% |
| Profit (INR Cr) | 162 62.7% | 99 61.2% | 62 -34.0% | 93 29.2% | 72 32.6% | 54 110.2% | 26 29.2% | 20 281.2% | 5 - | -21 - | -1 - | -90 - | 20 -69.2% | 64 11.3% | 58 -22.0% | 74 - |
| Assets (INR Cr) | 723 19.6% | 604 14.6% | 528 11.1% | 475 24.4% | 382 26.0% | 303 19.4% | 254 12.6% | 225 33.3% | 169 11.3% | 152 -11.8% | 172 71.7% | 100 -47.2% | 190 3.6% | 183 26.8% | 145 -19.1% | 179 - |
| Net Worth (INR Cr) | 712 20.9% | 589 15.1% | 511 12.1% | 456 25.2% | 364 21.2% | 301 21.8% | 247 10.8% | 223 42.9% | 156 3.5% | 151 -12.1% | 172 72.0% | 100 -47.3% | 189 5.3% | 180 24.3% | 145 24.4% | 116 -27.1% |
| Employee Cost (INR Cr) | 241 -6.8% | 259 12.6% | 230 4.9% | 220 1.3% | 217 9.8% | 197 31.3% | 150 -7.2% | 162 -4.3% | 169 6.0% | 160 -0.4% | 160 8.1% | 148 -8.3% | 162 7.6% | 151 85.1% | 81 33.8% | 61 - |
| Interest Cost (INR Cr) | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Cash & Bank Balance (INR Cr) | 506 | 500 | 448 | 352 | 253 | 173 | 126 | 116 | 77 | 25 | 89 | 18 | 53 | 85 | 68 | 144 |
| Total Debt (INR Cr) | 5 | 7 | 9 | 12 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 11.7% | 9.2% | 7.6% | 11.3% | 8.2% | 7.3% | 4.1% | 3.7% | 0.9% | - | - | - | 3.6% | 10.5% | 14.3% | 19.5% |
| Profit As % Of Assets | 22.4% | 16.4% | 11.7% | 19.7% | 18.9% | 18.0% | 10.2% | 8.9% | 3.1% | - | - | - | 10.4% | 35.0% | 39.9% | 41.3% |
| Profit As % Of Networth | 22.7% | 16.9% | 12.1% | 20.5% | 19.8% | 18.1% | 10.5% | 9.0% | 3.4% | - | - | - | 10.4% | 35.7% | 39.9% | 63.6% |
| Interest Cost to EBITDA % | 0.7% | 0.5% | 1.1% | 0.8% | 0.9% | - | - | - | - | - | - | - | - | - | 0.2% | 4.3% |
| Debt to Equity Ratio | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | - | - | - | - | - | - | - | - | - | - | 0.54 |
| RONW | 24.8% | 23.0% | 12.7% | 22.7% | 21.7% | 19.9% | 11.0% | 8.3% | 3.4% | - | - | - | 10.7% | 31.7% | 44.2% | 53.6% |
| ROCE | 33.3% | 30.5% | 16.8% | 29.9% | 33.6% | 26.1% | 18.3% | 14.2% | 3.6% | -12.9% | -12.1% | -48.5% | 15.7% | 47.9% | 54.8% | 70.6% |